88IV - PR Newswire Asia's news


Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited SHANGHAI , March 18, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs SHANGHAI and HONG KONG , March 18, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy TAIPEI and SAN DIEGO , March 18, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases IN026 is a potential first-in-class mRNA therapy for refractory gout, marking the emergence of a new category of mRNA medicines enabled by Innorna's proprietary mRNA–LNP platform. ... 2026-03-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306 AP306 is a first-in-class pan-phosphate transporter inhibitor in development for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) receiving dialysis ... 2026-03-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ribo to present ex-hepatic delivery data at RNA Leaders Europe Conference SUZHOU, China and MÖLNDALS, Sweden , March 17, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) ... 2026-03-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027 SUZHOU, China , March 17, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (study code: JSKN027-101) ... 2026-03-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
BioCina Initiates Comprehensive Manufacturing Program for Patrys' Proprietary Injectable Therapeutic to Alleviate Delirium PERTH, Australia , March 17, 2026 /PRNewswire/ -- BioCina Pty Ltd ., a global end-to-end Contract Development and Manufacturing Organisation (CDMO) announced it has initiated a comprehensive CMC (Chemistry, ... 2026-03-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA SHANGHAI , March 17, 2026 /PRNewswire/ -- Monday, March 16 th at 1:30 PM PT , Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, ... 2026-03-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth Group Performance ... 2026-03-16T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology